Addressing Logistical Challenges of CAR T Therapy Administration in Inpatient, Outpatient Settings
August 2nd 2021Pharmacy Times interviewed Craig Freyer, PharmD, BCOP, and Andrew Lin, PharmD, BCOP, to discuss how to manage the logistical challenges that arise during the administration of CAR T therapy in inpatient and outpatient settings for patients with multiple myeloma.
Pharmacist Medication Insights: Phesgo for HER2-Positive Breast Cancer
July 26th 2021The combination of pertuzumab, trastuzumab and hyaluronidase–zzxf is indicated for adult patients with HER2-positive breast cancer that has spread to other parts of the body and for adult patients with early HER2-positive breast cancer.